当前位置:主页 > 医学论文 > 肿瘤论文 >

艾迪注射液改善乳腺癌患者情绪及生活质量的临床观察

发布时间:2018-12-20 11:58
【摘要】:目的:观察艾迪注射液是否可以改善乳腺癌患者抑郁、焦虑情绪。观察艾迪注射液是否可以改善乳腺癌患者生活质量。材料与方法:选取辽宁省肿瘤医院内一科2016年3月至2016年8月住院的乳腺癌患者,共50例。采用前瞻性随机对照临床研究方法,将符合条件的患者随机分成试验组(n=24)和对照组(n=26)。试验组,在常规西医治疗的同时,静滴艾迪注射液(10 m L/支),100 m L+加入0.9%氯化钠注射液或5%葡萄糖注射液400-450ml静脉点滴,每日1次,连续治疗7日,停药14日,21日为1周期,连续应用2周期。对照组:空白对照,只接受常规西医治疗。记录第1周期开始和第2周期结束,两组患者焦虑自评量表(SAS)、抑郁自评量表(SDS)及生活质量调查表(QLQ-C30)评分,观察评分变化情况,同时观察艾迪注射液的不良反应。结果:1.试验组和对照组,两组患者在性别、年龄、体力状况评分、临床分期方面具有较好的均衡性,(均有P0.05)。2.试验组和对照组两组肿瘤缓解率(ORR)比较,检验结果:P0.05没有统计学意义。3.试验组治疗前后焦虑量表评分比较,检验结果:P0.05有统计学差异,治疗后优于治疗前;对照组治疗前后焦虑量表评分比较,检验结果:P0.05无统计学差异;试验组和对照组治疗后组间焦虑量表评分比较,检验结果:P0.05有统计学差异,试验组优于对照组。4.试验组治疗前后抑郁量表评分比较,检验结果:P0.05有统计学差异,治疗后优于治疗前;对照组治疗前后抑郁量表评分比较,检验结果:P0.05无统计学差异;试验组和对照组治疗后组间抑郁量表评分比较,检验结果:P0.05有统计学差异,试验组优于对照组。5.试验组治疗前后生活质量调查表各项评分比较,检验结果:疲倦症状领域和总体健康状况领域评分P0.05有统计学差异,治疗后优于治疗前,其余各项检验结果:P0.05均无统计学差异;对照组治疗前后生活质量调查表各项评分比较,疲倦、腹泻症状领域评分P0.05有统计学差异,治疗前优于治疗后,其余各项检验结果:P0.05均无统计学差异。结论:1.艾迪注射液可改善乳腺癌患者的抑郁情绪。2.艾迪注射液可改善乳腺癌患者的焦虑情绪。3.艾迪注射液可改善乳腺癌患者的生活质量。
[Abstract]:Objective: to observe whether Aidi injection can improve depression and anxiety in breast cancer patients. To observe whether Aidi injection can improve the quality of life of breast cancer patients. Materials and methods: 50 breast cancer patients from March 2016 to August 2016 in Liaoning Cancer Hospital were selected. Prospective randomized controlled clinical study was used to randomly divide the eligible patients into two groups: the trial group (n = 24) and the control group (n = 26). In the experimental group, Aidi injection (10 mL / branch) was injected intravenously with 0.9% sodium chloride injection or 5% glucose injection 400-450ml intravenously at the same time of routine western medicine treatment for 7 consecutive days. Drug withdrawal for 14 days, 21 days for 1 cycle, continuous application of 2 cycles. Control group: blank control group, only accepted routine western medicine treatment. At the beginning of the first cycle and the end of the second cycle, the scores of self-rating anxiety scale (SAS), self-rating depression scale (SDS) and quality of life (QLQ-C30) were recorded, and the changes of the scores were observed. At the same time, the adverse reactions of Aidi injection were observed. Results: 1. Test group and control group, the two groups of patients in gender, age, physical strength scores, clinical stages have a better balance, (P0.05). 2. Test group and control group tumor remission rate (ORR) comparison, test results: P0.05 no statistical significance. The test group before and after treatment anxiety scale score comparison, test results: P0.05 has statistical difference, after treatment is better than before treatment; the control group before and after treatment anxiety scale score comparison, test results: P0.05 no statistical difference; Test group and control group after treatment between the anxiety scale score comparison, test results: P0.05 has statistical difference, the test group is better than the control group. 4. Test group before and after treatment depression scale score comparison, test results: P0.05 has statistical difference, after treatment is better than before treatment; the control group before and after treatment depression scale score comparison, test results: P0.05 no statistical difference; Test group and control group after treatment between the depression scale score comparison, test results: P0.05, the test group is better than the control group. 5. The scores of QOL questionnaire were compared before and after treatment in the trial group. The results showed that there were significant differences in the scores of fatigue symptom area and general health status (P0.05), which were better than those before and after treatment. The other test results: P0.05, there was no statistical difference; Control group before and after treatment quality of life questionnaire scores, fatigue, diarrhea symptoms P05 scores were statistically significant, before treatment than after treatment, the rest of the test results: P0.05 no statistical difference. Conclusion: 1. Aidi injection can improve depression in breast cancer patients. 2. 2. Eddie injection can improve anxiety in breast cancer patients. Eddie injection can improve the quality of life of breast cancer patients.
【学位授予单位】:辽宁中医药大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R737.9

【参考文献】

相关期刊论文 前10条

1 张恒伟;李军涛;郭旭辉;吕民豪;秦丽;卢振铎;李连方;崔树德;刘真真;;乳腺癌新辅助化疗患者病理完全缓解的影响因素及生存分析[J];中国肿瘤临床;2016年18期

2 王慧杰;王朝霞;万冬桂;李佩文;;乳腺癌分子分型指导下的中医治疗思路与方法[J];中国中西医结合杂志;2016年04期

3 杨磊;鱼星锋;李妍;李小妹;;女性人格特征、情绪控制与乳腺癌发生危险的相关分析[J];中国健康心理学杂志;2016年02期

4 张淑萍;王亚军;胡春荣;吴成吉;宣兆博;刘文娟;杨利敏;黄作义;;刺五加提取物对睡眠剥夺小鼠抗氧化抗疲劳的研究[J];黑龙江医药科学;2015年06期

5 念家云;孙旭;张兴;郭佼;王笑民;;艾迪注射液联合化疗治疗乳腺癌的Meta分析[J];中华中医药学刊;2015年12期

6 沈润;何洪生;梁彩霞;;艾迪注射液配合化疗对恶性肿瘤化疗患者生活质量及抑郁的影响[J];齐齐哈尔医学院学报;2015年34期

7 钟祖军;;从中医“情志”谈肿瘤[J];世界最新医学信息文摘;2015年34期

8 缪华媛;冯平;钱荣;顾翩翩;季进锋;;百乐眠胶囊治疗恶性肿瘤相关性抑郁症的疗效观察[J];中国继续医学教育;2015年30期

9 史琳;富琦;许炜茹;杨国旺;江泽飞;张少华;万冬桂;武彪;傅莹;郭勇;杨维泓;卓睿;王笑民;;中医辨证治疗乳腺癌术后高危人群的疗效评价[J];临床肿瘤学杂志;2015年10期

10 张晶;;中医疗法治疗肿瘤伴发抑郁症54例疗效观察[J];临床医药文献电子杂志;2015年29期

相关硕士学位论文 前4条

1 田雪芹;天然产物鸦胆子和粉防己的化学成分研究[D];东华大学;2014年

2 梁云蕾;中西医结合优化方案治疗肢体淋巴水肿的临床观察[D];黑龙江中医药大学;2013年

3 陈建华;孙桂芝教授病证结合治疗乳腺癌经验整理与临床研究[D];中国中医科学院;2012年

4 付亚斐;中医情志因素与乳腺癌发生的相关性研究[D];广州中医药大学;2009年



本文编号:2387966

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/zlx/2387966.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户d8248***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com